» Articles » PMID: 17765528

COPD Exacerbations: Defining Their Cause and Prevention

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2007 Sep 4
PMID 17765528
Citations 472
Authors
Affiliations
Soon will be listed here.
Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD.

Citing Articles

Natural killer cells in the lung: novel insight and future challenge in the airway diseases.

Pianigiani T, Paggi I, Cooper G, Staples K, McDonnell M, Bergantini L ERJ Open Res. 2025; 11(2).

PMID: 40071269 PMC: 11895099. DOI: 10.1183/23120541.00683-2024.


The Role of Severe Vitamin D Deficiency in Predicting the Risk of Severe Exacerbation in Patients With Chronic Obstructive Pulmonary Disease.

Zhou L, Han C, Zhou Y Int J Chron Obstruct Pulmon Dis. 2025; 20:171-179.

PMID: 39867990 PMC: 11766290. DOI: 10.2147/COPD.S489650.


Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.

Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E Medicina (Kaunas). 2025; 61(1).

PMID: 39859079 PMC: 11766895. DOI: 10.3390/medicina61010097.


Exploring risk factors for all-cause hospital readmissions following chronic obstructive pulmonary disease exacerbation patients discharged on steroid tapers.

Simpson M, Kapfumvuti R, Niranjan S, Sherman M, Hassan A, Mutabi E J Thorac Dis. 2025; 16(12):8538-8549.

PMID: 39831232 PMC: 11740058. DOI: 10.21037/jtd-24-932.


Wnt3a Enhances Mesenchymal Stem Cell Engraftment and Differentiation in a Chronic Obstructive Pulmonary Disease Rat Model.

Wu H, Zhong Y, Li Y, Zhou X, Zhao T, Wan D Int J Chron Obstruct Pulmon Dis. 2025; 20():69-81.

PMID: 39802038 PMC: 11725259. DOI: 10.2147/COPD.S486262.


References
1.
Tillie-Leblond I, Marquette C, Perez T, Scherpereel A, Zanetti C, Tonnel A . Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006; 144(6):390-6. DOI: 10.7326/0003-4819-144-6-200603210-00005. View

2.
Wongsurakiat P, Maranetra K, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S . Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest. 2004; 125(6):2011-20. DOI: 10.1378/chest.125.6.2011. View

3.
Jones P, Willits L, Burge P, Calverley P . Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J. 2003; 21(1):68-73. DOI: 10.1183/09031936.03.00013303. View

4.
Donaldson G, Seemungal T, Patel I, Bhowmik A, Wilkinson T, Hurst J . Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005; 128(4):1995-2004. PMC: 7172405. DOI: 10.1378/chest.128.4.1995. View

5.
. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980; 93(3):391-8. DOI: 10.7326/0003-4819-93-3-391. View